BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11032738)

  • 1. Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase enzyme.
    Ohgami N; Kuniyasu A; Furukawa K; Miyazaki A; Hakamata H; Horiuchi S; Nakayama H
    Biochem Biophys Res Commun; 2000 Oct; 277(2):417-22. PubMed ID: 11032738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glibenclamide inhibits cholesterol metabolism in macrophage].
    Nakayama H; Ohgami N; Kuniyasu A; Miyazaki A; Hakamata H; Horiuchi S
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():150P-153P. PubMed ID: 10629872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and high-density lipoprotein-induced cholesterol efflux in macrophages.
    Azuma Y; Kawasaki T; Ikemoto K; Ohno K; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1999 Feb; 79(2):159-67. PubMed ID: 10202851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.
    Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
    Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
    Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage colony-stimulating factor regulates both activities of neutral and acidic cholesteryl ester hydrolases in human monocyte-derived macrophages.
    Inaba T; Shimano H; Gotoda T; Harada K; Shimada M; Kawamura M; Yazaki Y; Yamada N
    J Clin Invest; 1993 Aug; 92(2):750-7. PubMed ID: 8394386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esculeogenin A, a new tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in ApoE-deficient mice by inhibiting ACAT.
    Fujiwara Y; Kiyota N; Hori M; Matsushita S; Iijima Y; Aoki K; Shibata D; Takeya M; Ikeda T; Nohara T; Nagai R
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2400-6. PubMed ID: 17872457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages.
    Murakami S; Yamagishi I; Asami Y; Sato M; Tomisawa K
    Cell Mol Biol (Noisy-le-grand); 1996 Sep; 42(6):865-72. PubMed ID: 8891354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an anti-oxidative ACAT inhibitor on apoptosis/necrosis and cholesterol accumulation under oxidative stress in THP-1 cell-derived foam cells.
    Miike T; Shirahase H; Jino H; Kunishiro K; Kanda M; Kurahashi K
    Life Sci; 2008 Jan; 82(1-2):79-84. PubMed ID: 18037448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.
    de Medina P; Payré BL; Bernad J; Bosser I; Pipy B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1165-73. PubMed ID: 14617686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
    Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
    Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the monooxygenase activity inhibitor ketoconazole on cholesterol esterification in mouse peritoneal macrophages].
    Dushkin MI; Mandrikova EV; Liubimov GIu; Vol'skiĭ NN; Dolgov AV
    Biokhimiia; 1990 Sep; 55(9):1607-15. PubMed ID: 2078637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.
    Ikenoya M; Yoshinaka Y; Kobayashi H; Kawamine K; Shibuya K; Sato F; Sawanobori K; Watanabe T; Miyazaki A
    Atherosclerosis; 2007 Apr; 191(2):290-7. PubMed ID: 16820149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
    Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
    López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C
    Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of acyl-CoA:cholesterol acyltransferase in Chinese hamster ovary (CHO) cells by short-chain ceramide and dihydroceramide.
    Ridgway ND
    Biochim Biophys Acta; 1995 Apr; 1256(1):39-46. PubMed ID: 7742354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of F-1394, a potent and selective inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), on esterification of cholesterol and basolateral secretion of cholesteryl ester in Caco-2 cells].
    Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H
    Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):357-65. PubMed ID: 9503394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
    Burrier RE; Smith AA; McGregor DG; Hoos LM; Zilli DL; Davis HR
    J Pharmacol Exp Ther; 1995 Jan; 272(1):156-63. PubMed ID: 7815329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.